PHARMACOKINETIC INTERACTION BETWEEN TEGOPRAZAN AND METRONIDAZOLE/TETRACYCLINE/BISMUTH IN HEALTHY KOREAN SUBJECTS.

被引：0
作者：
Kim, M. [1 ]
Jeong, Y. [1 ]
Park, J. [1 ]
Moon, S. [1 ]
机构：
[1] Chonbuk Natl Univ Hosp, Jeonju Si, Jeollabuk Do, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-087
引用
收藏
页码：S59 / S59
页数：1
相关论文
共 50 条
[41]   COMPARISION OF ACID-SUPPRESSION AND SAFETY BETWEEN TEGOPRAZAN 50 MG AND REVAPRAZAN 200 MG IN HEALTHY MALE SUBJECTS. [J].
Ban, M. ;
Sunwoo, J. ;
Kim, J. ;
Ji, S. ;
Lee, H. -K. ;
Nam, J. ;
Song, G. ;
Yu, K. -S. ;
Lee, S. ;
Jang, I. -J. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 :S52-S52
[42]   Effect of rifampin on the pharmacokinetics of rosiglitazone in Korean healthy subjects. [J].
Park, J ;
Kim, K ;
Jung, W ;
Kim, S ;
Shin, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) :P34-P34
[43]   A PHARMACOKINETIC INTERACTION ASSESSMENT BETWEEN A NOVEL CYCLOPHILIN INHIBITOR ALISPORIVIR (ALV) AND A MACROLIDE ANTIBIOTIC AZITHROMYCIN (AZI) IN HEALTHY SUBJECTS. [J].
Ke, J. ;
Barve, A. ;
Kovacs, S. ;
Dabovic, K. ;
Praestgaard, J. ;
Zhang, J. ;
Stein, D. ;
Sunkara, G. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 :S116-S116
[44]   Lack of pharmacokinetic interaction between multiple doses of the dipepttdyl peptidase-4 inhibitor alogliptin and digoxin in healthy subjects. [J].
Karim, A. ;
Fleck, P. ;
Harris, S. ;
Weiss, M. ;
Zhang, W. ;
Mekki, Q. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 :S12-S13
[45]   PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS BETWEEN EVOGLIPTIN AND METFORMIN AFTER ORAL ADMINISTRATION IN HEALTHY SUBJECTS. [J].
Rhee, S. ;
Jang, K. ;
Lee, J. ;
Cho, Y. ;
Choi, Y. ;
Yoon, S. ;
Cho, J. ;
Lee, H. ;
Yu, K. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 :S51-S51
[46]   Pharmacokinetic and Pharmacodynamic Interaction Between Gemigliptin and Metformin in Healthy Subjects [J].
Dongseong Shin ;
Young Min Cho ;
SeungHwan Lee ;
Kyoung Soo Lim ;
Jeong-Ae Kim ;
Ji-Yung Ahn ;
Joo-Youn Cho ;
Howard Lee ;
In-Jin Jang ;
Kyung-Sang Yu .
Clinical Drug Investigation, 2014, 34 :383-393
[47]   PHARMACOKINETIC DRUG INTERACTION BETWEEN NIPOCALIMAB AND FREMANEZUMAB IN HEALTHY SUBJECTS [J].
Bei, Di ;
Shao, Jie ;
Xu, Yan ;
Vermeulen, An .
MUSCLE & NERVE, 2022, 66 :S69-S69
[48]   Pharmacokinetic and Pharmacodynamic Interaction Between Tolvaptan and Warfarin in Healthy Subjects [J].
Shoaf, Susan E. ;
Mallikaarjun, Suresh .
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2012, 1 (02) :67-75
[49]   Pharmacokinetic interaction between eslicarbazepine acetate and lamotrigine in healthy subjects [J].
Nunes, Teresa ;
Maia, J. ;
Almeida, L. ;
Soares-da-Silva, P. .
EPILEPSIA, 2007, 48 :339-340
[50]   Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjects [J].
Stocker, Sophie L. ;
Williams, Kenneth M. ;
McLachlan, Andrew J. ;
Graham, Garry G. ;
Day, Richard O. .
CLINICAL PHARMACOKINETICS, 2008, 47 (02) :111-118
12345